Skip to product information
1 of 1

GeneBio Systems

Recombinant TSC22D1 Monoclonal Antibody

Recombinant TSC22D1 Monoclonal Antibody

SKU:AN300428P

Regular price $0.00 CAD
Regular price Sale price $0.00 CAD
Sale Sold out
Shipping calculated at checkout.

Size::

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Recombinant Antibodies;Monoclonal Antibodies

Abbreviation:TSC22D1

Target Synonym:TSC;Ptg;KIAA;hucep;TGFB1I;Tsc22d;Ptg-2;KIAA1994;TGFB1I4;TSC22;TSC22D1;hucep-2;TSC22 domain family member 1

Research Areas:Epigenetics and Nuclear Signaling

Conjugation:Unconjugated

Host:Rabbit

Species reactivity:Human

Application:ICC/IF

Isotype:IgG

Clonality:Monoclonal

Clone NO.:4B3

UNIProt ID:Q15714

Accession:

Background:TSC22 domain family, member 1 (TSC22D1) is one of the TGF-beta-stimulated clone-22 (TSC-22). TSC-22 was reported to be a differentiation-inducing factor that negatively regulates the growth of salivary gland cancer cells. TSC22D1, which encodes transforming growth factor beta-stimulated clone 22 (TSC-22), is thought to be a tumor suppressor because its expression is lost in many glioblastoma, salivary gland, and prostate cancers. TSC-22 is the founding member of the TSC-22/DIP/Bun family of leucine zipper transcription factors. TSC-22 may play an important role in maintaining the differentiated phenotype in salivary gland tumors, and may be a possible target of leukemia therapy. TSC22D1 forms homodimers via its conserved leucine zipper domain and heterodimerizes with TSC22D4. TSC22D1 has transcriptional repressor activity.

Concentration:1 mg/mL

Immunogen:Recombinant Human TSC22D1 Protein

Buffer:0.2 μm filtered solution in PBS

Purification method:Protein A

Dilution:ICC/IF 1:20-1:100

Calculated MW:

ObservedMW:

View full details